A federal jury in Georgia deliberated for 3 hours yesterday before delivering another loss to Johnson & Johnson (NYSE:JNJ) in a product liability lawsuit brought over pelvic mesh products. The jury in the U.S. District Court for Middle Georgia awarded plaintiff Teresa Taylor $400,000 in compensatory damages and $4 million in punitive damages after finding […]
January 21, 2015 by Brad Perriello
MASSDEVICE ON CALL — Health insurance companies stand to benefit the most from healthcare reform, but the industry is fighting hard in its efforts to repeal a levy which will go towards paying for Obamacare.
America’s Health Insurance Plans, or AHIP, the national trade association representing the health insurance industry, estimates that taxes on insurance plans scheduled to start in 2014 will net the Feds more than $100 billion over the next decade, as much as the medical device excise tax and pharmaceutical industry fee combined.
The medical device industry’s efforts to repeal an impending 2.3% tax on sales continue to run in high gear as Ohio’s med-tech industry discusses impacts with local legislators and a Congressional GOP group takes the rhetoric and runs with it.
Far from chilling the breast aesthetics market, the widespread breast implant recall in Europe may have an upside for device makers as patients opt to replace their potentially rupture-prone implants.
When French breast modification company Poly Implant Prosthèse was caught filling its breast implants with substandard silicone, rival implant makers took pains to distance themselves from the scandal for fear of being tangled in a PR nightmare.
The U.S. Supreme Court heard oral arguments this week in a case that could have wide-reaching implications for health care: Whether medical patents should be allowed.
At issue is the specter of doctors being sued for patent infringement based on treatment decisions derived from the scientific research underpinning the patent.
A Food & Drug Administration review found that women with breast implants have a greater chance of contracting a rare form of cancer than other women.
The federal watchdog agency warned doctors and patients of a possible link between saline- and silicone gel-filled breast implants and anaplastic large-cell lymphoma, a very rare type of cancer.
Johnson & Johnson (NYSE:JNJ) subsidiary Mentor Corp. agreed to settle a group of lawsuits filed against it over an allegedly defective device designed to treat female urinary incontinence.